Institute of Cancer and Genomic Sciences Using fundamental research and the power of genomics to develop better therapies in cancer and other complex diseases.
News World leading cancer trials in Birmingham get £10 million boost Adults and children with cancer will continue to benefit from world-class clinical trials led by the University of Birmingham
QS World University Subject Rankings released for 2023 University of Birmingham rises 30 places to be joint 62nd in the world for Life Sciences and Medicine.
06 October 2021 One in seven patients miss cancer surgery during COVID lockdowns - study One in seven cancer patients around the world have missed out on potentially life-saving operations during COVID-19 lockdowns, a new study reveals.
04 October 2021 Higher rates of mutation alone are not to blame for age-related disease, study finds Small mutations accumulating in DNA are unlikely to be fully responsible for the ageing process, finds a new study carried out in collaboration with the University of Birmingham.
13 September 2021 Scientists discover new pathway that prevents bowel cancer treatment from working Leading scientists at the University of Birmingham have discovered a previously unknown pathway that prevents specific drugs from working in patients with bowel cancer.
26 August 2021 Global COVID-19 surgery study scoops scientific world record A study led by University of Birmingham experts has been awarded the Guinness World Records title for the world's largest scientific collaboration.
26 August 2021 New study to test third COVID-19 vaccine for people with weakened immune systems A new clinical trial has launched in the UK to determine whether a third vaccine will improve the immune response of people who have weakened immune systems.
25 August 2021 Recent COVID-19 infection puts surgical patients at higher blood clot risk Surgical patients who have recently had COVID-19 are more likely to develop potentially fatal post-operative blood clots, a new global study reveals.